What is Helixor (Mistletoe Therapy)?

Helixor is a natural extract derived from the European mistletoe plant (Viscum album), used in integrative and functional medicine for its potential immune-modulating, anti-inflammatory and restorative properties. Originally developed as a complementary therapy in cancer care, Helixor is increasingly used in some integrative health settings for a range of health concerns, including chronic fatigue, burnout, immune dysfunction and inflammatory conditions.

Helixor is manufactured in Germany under pharmaceutical standards and is typically administered via injection. It is considered a complementary treatment that may support immune system activity and systemic balance when used alongside conventional therapies.

Note: Helixor is not licensed by the MHRA for the treatment of all these conditions in the UK and should not be seen as a substitute for standard medical care.

Why is Helixor Important to Our Health?
Helixor is primarily used in integrative oncology but has potential applications beyond cancer care as a biological response modifier. It may help support immune system regulation and recovery from stress or illness. However, current evidence is limited and Helixor should be regarded as an adjunct rather than a standalone treatment.
In non-cancer contexts, Helixor is sometimes used to:
• Support regulation of immune activity in cases of immune imbalance
• Assist with symptoms of fatigue and burnout
• Promote resilience during periods of physical or emotional strain

While some patients report benefits, these effects are not guaranteed and more high-quality research is needed to fully establish Helixor’s effectiveness for these indications.

Where is Helixor Most Commonly Used?
Helixor is most commonly used in Germany, Switzerland and parts of Central Europe as part of anthroposophic and integrative medicine, especially alongside cancer treatment. Use in the UK and North America is growing primarily in private integrative and functional medicine settings.

In all cases, Helixor should be administered under supervision by clinicians experienced with its use and as part of a broader, evidence-informed treatment plan.

How is Helixor Administered?
Helixor is typically given by subcutaneous injection, usually two to three times per week. Some clinical settings may use intravenous or intratumoural routes. Treatment starts with a low test dose, increasing gradually based on individual response and clinical judgement.

Administration is carefully supervised and some people may experience mild, temporary reactions such as local warmth, redness or low-grade fever, possible signs of immune system activation.

What Does the Research Say About Helixor?
A number of studies, mostly from Germany and Central Europe, have investigated Helixor’s effects:

• Immune modulation: Some evidence suggests Helixor may influence immune cells such as T-cells and natural killer cells
• Fatigue and burnout: Preliminary findings and clinical observations indicate potential symptom improvement, but larger controlled trials are needed
• Integrative oncology: Studies report possible benefits in reducing chemotherapy or radiotherapy side effects and improving quality of life, however these are not universally accepted outside specialised contexts
• Inflammation: Mild anti-inflammatory effects are proposed but require further research
Important: Current evidence is not conclusive and Helixor should be considered a complementary therapy, not a primary treatment.

Why Do People Choose Helixor?
Many patients seek Helixor as a natural, well-tolerated complementary option to support immune health, reduce fatigue and enhance wellbeing. It is valued for its gentle action and potential to support recovery alongside conventional medical care.
At Alchemy by Effect Doctors, we emphasise that Helixor is used responsibly as part of an integrative treatment plan. For patients undergoing cancer treatment, we always ensure your oncologist is fully informed and involved in decisions regarding Helixor use.

Important Safety Information and Disclaimer
• Helixor is not a licensed cure for cancer, chronic fatigue, autoimmune diseases or other health conditions in the UK
• It should never replace standard medical treatments or therapies prescribed by your healthcare team
• Possible side effects include local injection reactions and mild immune responses, serious adverse effects are rare but can occur
• Patients should discuss all complementary therapies with their primary care team or specialist
• Alchemy by Effect Doctors provides Helixor treatment only under clinical supervision by trained healthcare professionals
• Clinical decisions are always personalised, with full informed consent

Contact us
Alchemy by Effect Doctors offers Helixor mistletoe therapy in a safe, clinical setting tailored to your needs, whether for immune support, recovery from fatigue or adjunctive wellness care. Treatments are overseen by doctors and nurses trained in integrative medicine.
Please contact us for more information or to schedule an individual consultation. We prioritise coordination with your existing medical team to ensure safe, effective care.

Disclaimer
Helixor (mistletoe therapy) is a complementary treatment and is not licensed by the MHRA for the treatment of cancer, chronic fatigue, autoimmune or other conditions in the UK. It should not replace conventional medical care. Clinical evidence is limited and benefits are not guaranteed. Please consult your healthcare team before starting any new therapy. Alchemy by Effect Doctors ensures all treatments are supervised by trained clinicians and coordinated with your existing medical providers.